Portfolio (Quarterly)
Guide ↗
Mirae Asset Global Investments Co., Ltd.
· CIK 0001569395| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 761 | ANAB | ANAPTYSBIO INC | Healthcare | 1,444.0 | $53K | — | +99.0 | +7.4% | $36.97 | +38.9% |
| 762 | WWD | WOODWARD INC | Industrials | 149.0 | $53K | — | +3.0 | +2.0% | $357.92 | +0.5% |
| 763 | LYFT | LYFT INC | Technology | 4,006.0 | $53K | — | +873.0 | +27.9% | $13.30 | +5.4% |
| 764 | QURE | UNIQURE NV | Healthcare | 3,249.0 | $53K | — | +222.0 | +7.3% | $16.35 | +65.1% |
| 765 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 2,636.0 | $53K | — | +180.0 | +7.3% | $20.13 | +34.1% |
| 766 | RR | RICHTECH ROBOTICS INC | Industrials | 24,822.0 | $52K | — | +11K | +73.5% | $2.09 | +16.7% |
| 767 | — | INHIBRX BIOSCIENCES INC | — | 759.0 | $51K | — | +52.0 | +7.4% | $67.23 | — |
| 768 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 8,655.0 | $50K | — | +592.0 | +7.3% | $5.80 | +7.6% |
| 769 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 2,153.0 | $50K | — | +147.0 | +7.3% | $23.07 | +32.2% |
| 770 | GERN | GERON CORP | Healthcare | 33,296.0 | $50K | — | +2K | +7.3% | $1.49 | -24.2% |
| 771 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 2,112.0 | $48K | — | +21.0 | +1.0% | $22.60 | +1.2% |
| 772 | AMPH | AMPHASTAR PHARMACEUTICALS IN | Healthcare | 2,366.0 | $46K | — | +133.0 | +6.0% | $19.59 | -1.0% |
| 773 | XNCR | XENCOR INC | Healthcare | 3,825.0 | $46K | — | +355.0 | +10.2% | $12.06 | -5.4% |
| 774 | FTRE | FORTREA HLDGS INC | Healthcare | 4,877.0 | $46K | — | +387.0 | +8.6% | $9.42 | +75.9% |
| 775 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 4,110.0 | $46K | — | +653.0 | +18.9% | $11.11 | -10.0% |
| 776 | GHRS | GH RESEARCH PLC | Healthcare | 3,235.0 | $45K | — | +221.0 | +7.3% | $14.06 | +43.1% |
| 777 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 10,032.0 | $45K | — | +686.0 | +7.3% | $4.50 | -5.8% |
| 778 | CRBG | COREBRIDGE FINL INC | Financial Services | 1,869.0 | $45K | — | +41.0 | +2.2% | $23.86 | +13.7% |
| 779 | JANX | JANUX THERAPEUTICS INC | Healthcare | 3,173.0 | $44K | — | +250.0 | +8.6% | $13.90 | -2.8% |
| 780 | URGN | UROGEN PHARMA LTD | Healthcare | 2,442.0 | $44K | — | +167.0 | +7.3% | $17.98 | +51.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
41.2%
Communication Services
12.3%
Consumer Cyclical
10.0%
Healthcare
8.1%
Financial Services
7.7%
Industrials
6.8%
Consumer Defensive
5.9%
Energy
3.6%
Utilities
2.1%
Basic Materials
1.2%